Harvard Bioscience

Life Science Research Instrumentsharvardbioscience.com

Harvard Bioscience is a global developer and manufacturer of specialized life science instruments for preclinical research, serving academic institutions, pharmaceutical companies, biotechnology firms, CROs, and government laboratories across the US, Europe, and China through eleven wholly-owned brand subsidiaries.

Company typePublic
Founded1901
HeadquartersHolliston, United States
Headcount501–1,000
GTM typeB2B
OfferingHardware or Manufacturing

What Harvard Bioscience does

Harvard Bioscience, Inc. (NASDAQ: HBIO) is a global developer, manufacturer, and marketer of specialized life science instruments and equipment used in preclinical research, founded in 1901 and headquartered in Holliston, Massachusetts. The company operates through a multi-brand platform of eleven wholly-owned subsidiaries — Biochrom, BTX, CMA, DSI (Data Sciences International), HEKA, Harvard Apparatus, Hugo Sachs Elektronik, KD Scientific, Multi Channel Systems, Panlab, and Warner Instruments — serving academic research institutions, pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and government laboratories across the United States, Europe, and China.

The product portfolio spans spectrophotometers, amino acid analyzers, patch clamp amplifiers, microelectrode array (MEA) systems, preclinical telemetry, electroporation and electrofusion instruments, microdialysis equipment, behavior research systems, syringe pumps, and physiology research tools. Notable first-in-class products include the SoHo implantable continuous glucose telemetry system (continuous monitoring in freely-moving animals), INCUB8 multiwell MEA (simultaneous optical and electrophysiological recording), and SmartUSSING Ussing chamber (sub-10-second automatic amplifier calibration). The software layer includes Ponemah, a GLP- and 21 CFR Part 11-compliant data acquisition and analysis platform supporting studies from hours to weeks, alongside technical services such as surgical support, data services, GLP validation, and training.

Revenue is generated through a mix of one-time capital equipment sales, higher-margin recurring consumables and reagents, subscription software licensing, and professional services. Distribution combines direct enterprise field sales, ten brand-specific e-commerce sites, and a new Fisher Scientific distribution agreement launched Q2 2026. Current strategic priorities include the Project Viking manufacturing consolidation (closing Holliston, MA in favor of Minneapolis plus European sites, targeting $4 million in annual savings), a cGMP-compliant BTX product launch into bioproduction in H2 2026, debt refinancing with BroadOak Capital Partners completed December 2025, and a 1-for-10 reverse stock split executed in March 2026 to regain Nasdaq compliance. FY2025 revenue was $86.6 million with gross margin near 60% and adjusted EBITDA of $3.8 million in Q4 2025, up 27% year-over-year.

Harvard Bioscience firmographics

Firmographics

Name: Harvard Bioscience
Legal name: Harvard Bioscience Inc.
Website: https://harvardbioscience.com
Company type: Public
Founded year: 1901
Operating status: Operating
Headcount range: 501–1,000 employees
Short description: Harvard Bioscience is a global developer and manufacturer of specialized life science instruments for preclinical research, serving academic institutions, pharmaceutical companies, biotechnology firms, CROs, and government laboratories across the US, Europe, and China through eleven wholly-owned brand subsidiaries.
Ownership category
akta.pro rank

Harvard Bioscience industry classification

Industry

Product category: Life Science Research Instruments
NAICS: Analytical Laboratory Instrument Manufacturing (334516)
SIC: Laboratory Analytical Instruments (3826)
akta.pro primary industry: Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
akta.pro secondary industry: Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB)

Keywords

Life science instruments
Preclinical research equipment
Laboratory spectrophotometry
Electrophysiology measurement systems
Animal telemetry platforms

Where Harvard Bioscience is headquartered

Location

Headquarters

HQ city: Holliston
HQ country: United States
HQ region: North America

Offices5 records

Markets served

Harvard Bioscience business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

Life Science Instruments and Equipment: Sale of specialized instruments including spectrophotometers, amino acid analyzers, patch clamp amplifiers, microelectrode arrays, and telemetry systems for preclinical research.
Consumables and Reagents: Higher-margin consumables including reagents, buffer kits, columns, and spare parts for instruments. Management targeting expansion into higher-margin consumables revenue.
Software Licenses and Services: Software licensing including Ponemah software for data acquisition and analysis, with service packages including technical training and GLP validation services.
Technical and Support Services: Service offerings including surgical services, data services, GLP validation services, and technical training services.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Harvard Bioscience product offering

Product offering

Core offering

Harvard Bioscience develops, manufactures, and markets a portfolio of specialized scientific instruments, apparatus, and consumables used in preclinical life science research. Its offerings span spectrophotometers, amino acid analyzers, patch clamp amplifiers, microelectrode array (MEA) systems, implantable telemetry, electroporation systems, and behavior research equipment sold under multiple acquired brands (Biochrom, BTX, DSI, HEKA, Harvard Apparatus, Multi Channel Systems, Panlab, Warner Instruments, Hugo Sachs Elektronik, KD Scientific, CMA) to academic, pharmaceutical, biotech, CRO, and government laboratory customers.

Product overview

Harvard Bioscience operates as a life science tools company with a multi-brand platform strategy. The company develops, manufactures, and markets specialized instruments for preclinical research across academic institutions, pharmaceutical companies, biotech firms, and contract research organizations. The product portfolio is organized around acquired brands including Biochrom (spectrophotometers, amino acid analyzers), DSI (implantable telemetry, Ponemah software), HEKA (patch clamp amplifiers), Multi Channel Systems (MEA systems, INCUB8), BTX (electroporation), Warner Instruments (Ussing chambers), Panlab (metabolic systems), Harvard Apparatus, Hugo Sachs Elektronik, KD Scientific (infusion pumps), and CMA (microdialysis). These brands serve three primary market applications: discovery (neuroscience, electrophysiology, cellular technologies), production/bioprocessing (amino acid analysis, spectrophotometry for quality control), and safety/regulatory compliance (GLP-compliant software, preclinical telemetry). The company also offers scientific services including surgical services, data services, GLP validation, and technical training to support its instrument portfolio.

Differentiator

Problem solved

Functional benefit

Brands

Biochrom: Spectrophotometers, colorimeters, and amino acid analyzers for life science research and quality control applications.
BTX
CMA
DSI (Data Sciences International)
HEKA
Harvard Apparatus
Hugo Sachs Elektronik
KD Scientific
Multi Channel Systems
Panlab
Warner Instruments

Products and services

INCUB8 Multiwell MEA System First multiwell microelectrode array system offering simultaneous optical and electrophysiological data recording in a single instrument, enabling researchers to capture a more complete view of cellular events. Targeted at neuroscience, cellular electrophysiology, and organoid research customers.
HEKA EPC 10 USB 3.0 Patch Clamp Amplifier

Quantifiable outcome

Q4 2025 revenue of $23.7 million exceeding guidance with 60% gross margin at high end of guidance
+3 more outcomes

Companies that use Harvard Bioscience

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles3 records

Harvard Bioscience technology and API

Technology

Technology focussed Yes

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Harvard Bioscience partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

Fisher ScientificmajorChannel Partner/ Reseller/ Distributor · 1 January 2026New distribution agreement with Fisher Scientific expected to drive revenue starting Q2 2026. The partnership expands Harvard Bioscience's market reach through Fisher Scientific's extensive laboratory supply distribution network, supporting the company's growth initiatives targeting academic and pharmaceutical customers.

Scale indicators12 records

Recent moves9 records

Expansion highlights6 records

Harvard Bioscience competitors and assessment

Company assessment

Direct peers

Axion Biosystems: Direct competitor in microelectrode array (MEA) systems for cellular electrophysiology, overlapping with Harvard Bioscience's Multi Channel Systems brand in the same academic and pharma research accounts.
Molecular Devices (Danaher): Direct competitor in patch clamp amplifiers and electrophysiology instrumentation (Axopatch, MultiClamp), competing head-to-head with HEKA in academic neuroscience and ion channel research labs.
TSE Systems: Direct competitor in preclinical telemetry and metabolic/behavior phenotyping, overlapping with DSI implantable telemetry and Panlab metabolic cages in CRO and academic preclinical research.
emka TECHNOLOGIES: Direct competitor in preclinical telemetry, ECG, and respiratory monitoring for animal research, closely overlapping with DSI's telemetry product line in safety pharmacology studies.
Sutter Instrument: Direct competitor in micropipette pullers, micromanipulators, and electrophysiology accessories used in patch clamp and single-cell recording workflows alongside HEKA equipment.
Stoelting Co. Direct competitor in behavior research equipment including activity monitoring, learning/memory tests, and metabolic cages, overlapping with Panlab in neuroscience and behavioral pharmacology research.

Broad incumbents

Bio-Rad Laboratories: Broader life science tools incumbent with electroporation systems (Gene Pulser) directly competing with BTX, plus broader cell biology and life science research products targeting overlapping pharma and academic customers.

Emerging players

Standard BioTools (formerly Fluidigm): Smaller life science tools peer in mass cytometry and spatial biology with some MEA-adjacent cellular analysis; comparable in scale and similarly positioned in niche cell biology research markets.
MaxWell Biosystems: Emerging high-density MEA player focused on single-cell and neuron-level electrophysiology, competing in the same cell biology and neuroscience research accounts as Multi Channel Systems.
NPI Electronic: Specialized German manufacturer of electrophysiology amplifiers and signal processing equipment, competing with HEKA in single-channel and intracellular recording research applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Harvard Bioscience compliance and trust

Trust signal

Compliance3 records

Harvard Bioscience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Harvard Bioscience leadership team

Management profile

Number of profiles

Profiles6 records

Harvard Bioscience subsidiaries and ownership

Company hierarchy

Subsidiaries11 records

Harvard Bioscience funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Harvard Bioscience M&A and investment

M&A and investment

M&A22 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Harvard Bioscience

What does Harvard Bioscience do?

Is Harvard Bioscience a public or private company?

Harvard Bioscience is a public company. It is classified as public and is currently operating.

When was Harvard Bioscience founded?

Harvard Bioscience was founded in 1901. It employs 501 to 1,000 people.

Where is Harvard Bioscience based?

Harvard Bioscience is headquartered in Holliston, United States, in the North America region.

How does Harvard Bioscience make money?

Four revenue lines are on record. Life Science Instruments and Equipment is the primary driver. The others are consumables and Reagents, software Licenses and Services and technical and Support Services.

Who are Harvard Bioscience's main competitors?

Direct peers on record are Axion Biosystems, Molecular Devices (Danaher), TSE Systems, emka TECHNOLOGIES, Sutter Instrument and Stoelting Co.. Bio-Rad Laboratories is listed as a broad incumbent. Emerging players are Standard BioTools (formerly Fluidigm), MaxWell Biosystems and NPI Electronic.

Does Harvard Bioscience have an API?

No public API is recorded for Harvard Bioscience.

What industry is Harvard Bioscience in?

Harvard Bioscience's product category is Life Science Research Instruments. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments. Its NAICS code is 334516 and its SIC code is 3826.